Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression.
about
Biomarkers for glioma immunotherapy: the next generationAngiogenic growth factors in neural embryogenesis and neoplasiaPhase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastomaA Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma.Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiologyDifferential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growthEndothelial cell implantation and survival within experimental gliomas.Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissuesA phase I/II trial of vandetanib for patients with recurrent malignant glioma.Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimenAstrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas.Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant gliomaCost-effectiveness analysis of the bevacizumab-irinotecan regimen in the treatment of primary glioblastoma multiforme recurrences.FGF1 C-terminal domain and phosphorylation regulate intracrine FGF1 signaling for its neurotrophic and anti-apoptotic activitiesFGF1 protects neuroblastoma SH-SY5Y cells from p53-dependent apoptosis through an intracrine pathway regulated by FGF1 phosphorylation.
P2860
Q26825496-63CAF0CE-028F-4A47-96D8-B5FDCFD4C599Q30498863-AB363A8A-79C1-4883-80B4-B09ED9C176E6Q33382596-850D2ED3-0D48-43E9-AEBD-86CC284C22B1Q33913465-0E7D4BA3-23F7-4A2C-9339-71B2F74B6B05Q34435505-7D0CE99A-83B8-4B05-BDC6-F260CAED24A3Q34978609-D3B1A48A-CD77-4137-BAD9-2A0F0224E6B5Q35765074-A771A386-9343-4709-8256-39F1098DB93AQ35807668-8C1C1A03-5919-442F-8A92-C9F5DFF14896Q35823939-7AE91A4B-15D7-4233-A1C2-D0534F86DA11Q35994177-D389AB65-2F8B-4DC9-A84C-8563EFA53F4EQ36401846-12AD17AA-240B-4F80-8288-EF3BEBDD6366Q36403376-F9636547-C804-4F6C-A181-04114D4A20F2Q36553577-489BDA4A-4EC7-4BDB-9EA9-ABB0C8257D36Q36808787-9D5F2BC7-8B20-4EE2-981D-FC759227CA39Q37204582-E0784198-93DA-4826-A74C-0416A0EA792DQ40756986-BA332D07-E0FC-470B-ACED-EE46483B5ED0Q42358220-6FD24B14-5717-4A5E-B886-FAB598232DA9
P2860
Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Expression of angiogenic growt ...... their growth and progression.
@en
Expression of angiogenic growt ...... their growth and progression.
@nl
type
label
Expression of angiogenic growt ...... their growth and progression.
@en
Expression of angiogenic growt ...... their growth and progression.
@nl
prefLabel
Expression of angiogenic growt ...... their growth and progression.
@en
Expression of angiogenic growt ...... their growth and progression.
@nl
P2093
P1433
P1476
Expression of angiogenic growt ...... their growth and progression.
@en
P2093
Antoniades HN
Galanopoulos T
Hedley-Whyte ET
Neville-Golden J
P304
P407
P577
1991-02-01T00:00:00Z